Introduction: There is no approved topical prescription medicine to treat molluscum contagiosum (MC). SB206 is an investigational topical product that consists of 2 components; a gel containing berdazimer sodium that releases nitric oxide (NO) when co-administered with a hydrogel. NO, an endogenous small molecule, is known to be an immune modulator as well as an antimicrobial agent. Objective: A Phase 2, 12-week, randomized, vehiclecontrolled ascending dose trial was conducted in patients with MC to evaluate the efficacy and safety of SB206 compared to vehicle (VH). Materials and Methods: Patients 2 years of age were randomized 3:1 (active: vehicle) to ascending, sequential dose groups of SB206. After 30 patients randomized in a dose group completed 2 weeks of treatment, the Data Safety Monitoring Board reviewed unblinded safety and tolerability data and recommended to open the higher dose group. Consequently, 256 patients were randomized into the following dose groups: 47 (4% BID), 48 (8% BID), 47 (12% BID), 48 (12% QD) and 66 (VH). The primary endpoint was the proportion of patients demonstrating complete clearance of MC at Week 12 in the modified intent-to-treat (mITT) population. Results: The following proportion of patients achieved complete clearance at Week 12: 13.2% and 10.6% (4% BID), 41.0% and 33.3% (8% BID), 35.1% and 27.7% (12% BID), 41.9% and 37.5 % (12% QD) and 20.0% and 18.2% (VH) in the mITT and ITT population, respectively. The efficacy signals appeared as early as 2 weeks. There were no SAEs or deaths. The number (%) of patients who discontinued treatment due to AEs were 0 in vehicle group and 7 (4%) in the combined SB206 groups. The majority of AEs were application site reactions. No quantifiable systemic exposure of SB206 was observed. Conclusions: Overall, SB206 was well tolerated and efficacious in treating MC in this study and further studies are warranted.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.